High cost of hepatic encephalopathy treatment may lead to medication non-adherence

Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were associated with decreased treatment retention for patients.

Related Keywords

United States ,Danielle Ellis ,College Of Pharmacy ,M Health Fairview ,Phepatology Communications ,University Of Minnesota Medical School ,Minnesota Medical School ,Assistant Professor ,Liver ,Liver Disease ,Rain ,Ncephalopathy ,Hepatic Encephalopathy ,Hepatology ,Medical School ,Ortality ,Pharmacy ,Research ,